Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Norbeepee is a polyherbal Ayurvedic formulation developed by AVN Ayurveda Pharmaceuticals for the management of hypertension and associated anxiety. It is composed of five primary herbal ingredients: *Rauwolfia serpentina* (Sarpagandha), *Acorus calamus* (Vacha), *Inula racemosa* (Pushkarmool), *Vetiveria zizanioides* (Usira), and *Berberis aristata* (Daruharidra). The formulation exerts its antihypertensive effects through multiple mechanisms, including sympatholytic activity (primarily via reserpine in Sarpagandha), peripheral vasodilation, and mild diuretic action. Additionally, it possesses anxiolytic properties that help manage stress-related hypertension. It is administered orally and is marketed in India as a natural alternative for blood pressure control.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Norbeepee (AVN Ayurveda Formulations).